These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 10682910

  • 1. Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres.
    Hsu YY, Hao T, Hedley ML.
    J Drug Target; 1999 Dec; 7(4):313-23. PubMed ID: 10682910
    [Abstract] [Full Text] [Related]

  • 2. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
    Díez S, Tros de Ilarduya C.
    Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
    [Abstract] [Full Text] [Related]

  • 3. Water-soluble betamethasone-loaded poly(lactide-co-glycolide) hollow microparticles as a sustained release dosage form.
    Chaw CS, Yang YY, Lim IJ, Phan TT.
    J Microencapsul; 2003 Jun; 20(3):349-59. PubMed ID: 12881115
    [Abstract] [Full Text] [Related]

  • 4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H, Emami J, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2009 Nov 01; 74(1):340-9. PubMed ID: 19717287
    [Abstract] [Full Text] [Related]

  • 5. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
    Leo E, Pecquet S, Rojas J, Couvreur P, Fattal E.
    J Microencapsul; 1998 Nov 01; 15(4):421-30. PubMed ID: 9651864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O, Serhatlı M, Baysal K, Baysal BM.
    J Microencapsul; 2011 Nov 01; 28(1):46-54. PubMed ID: 21171816
    [Abstract] [Full Text] [Related]

  • 9. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
    Virto MR, Elorza B, Torrado S, Elorza Mde L, Frutos G.
    Biomaterials; 2007 Feb 01; 28(5):877-85. PubMed ID: 17064761
    [Abstract] [Full Text] [Related]

  • 10. Encapsulation of plasmid DNA in PLGA-stearylamine microspheres: a comparison of solvent evaporation and spray-drying methods.
    Atuah KN, Walter E, Merkle HP, Alpar HO.
    J Microencapsul; 2003 Feb 01; 20(3):387-99. PubMed ID: 12881118
    [Abstract] [Full Text] [Related]

  • 11. Protein delivery from poly(lactic-co-glycolic acid) biodegradable microspheres: release kinetics and stability issues.
    Crotts G, Park TG.
    J Microencapsul; 1998 Feb 01; 15(6):699-713. PubMed ID: 9818948
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 01; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

  • 14. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G, Kosvintsev SR, Stillwell MT, Holdich RG.
    Colloids Surf B Biointerfaces; 2008 Feb 15; 61(2):199-207. PubMed ID: 17919891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C, Griebenow K.
    Biotechnol Bioeng; 2003 Jun 30; 82(7):825-32. PubMed ID: 12701149
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo evaluations of PLGA microsphere vaccine formulations containing pDNA coexpressing hepatitis B surface antigen and Interleukin-2.
    Eratalay A, Coşkun-Ari FF, Oner F, Ozcengīz E.
    J Microencapsul; 2010 Jun 30; 27(1):48-56. PubMed ID: 19545223
    [Abstract] [Full Text] [Related]

  • 18. Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride.
    O'Donnell PB, McGinity JW.
    Eur J Pharm Biopharm; 1998 Jan 30; 45(1):83-94. PubMed ID: 9689539
    [Abstract] [Full Text] [Related]

  • 19. A novel preparation method for PLGA microspheres using non-halogenated solvents.
    Matsumoto A, Kitazawa T, Murata J, Horikiri Y, Yamahara H.
    J Control Release; 2008 Aug 07; 129(3):223-7. PubMed ID: 18562036
    [Abstract] [Full Text] [Related]

  • 20. Process considerations related to the microencapsulation of plasmid DNA via ultrasonic atomization.
    Ho J, Wang H, Forde GM.
    Biotechnol Bioeng; 2008 Sep 01; 101(1):172-81. PubMed ID: 18646229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.